Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy

E-ISSN： 1440-1746|25|6|1023-1025

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.25, Iss.6, 2010-06, pp. : 1023-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Predictors of non-adherence to systemic oral therapy for advanced hepatocellular carcinoma

By Mallick Rajiv Cai Jennifer Wogen Jenifer

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1701-1708

Informa Healthcare

Access to resources Recommend Favorite

Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2988-2995

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma

Oncology Research and Treatment, Vol. 31, Iss. 10, 2008-09 ,pp. : 550-555

Karger

Access to resources Recommend Favorite

Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 67-71

Karger

Access to resources Recommend Favorite